Status:
COMPLETED
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
Lead Sponsor:
Anhui Provincial Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The goal of this observational study is to construct a predictive model for improving the diagnostic accuracy in patients with PI-RADS score of 3. The main aims of this study are: * Construct a diagn...
Detailed Description
For patients with a PI-RADS score of 3, the diagnosis of prostate cancer is still use prostate biopsy, but the detection rates of prostate cancer and clinically significant prostate cancer are approxi...
Eligibility Criteria
Inclusion
- Patients with clinically suspected prostate cancer (abnormal PSA level or DRE);
- All patients have undergone mpMRI and have complete imaging data;
- The PI-RADS score of patients was 3;
- Prostate biopsy was performed and has clear pathological results.
Exclusion
- The patient's serum tPSA is \<4ng/ml or \>100ng/ml;
- Repeated prostate biopsy;
- The patient's clinical, imaging, or pathological data are incomplete.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT06507462
Start Date
January 1 2021
End Date
October 31 2024
Last Update
February 11 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China, 233000
2
Department of Urology, The First Affiliated Hospital of USTC
Hefei, Anhui, China, 230001
3
Department of Urology, The First Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China, 241000